Profile for Slovenia Patent: 2120963
✉ Email this page to a colleague
US Patent Family Members and Approved Drugs for Slovenia Patent: 2120963
| US Patent Number | US Expiration Date | US Applicant | US Tradename | Generic Name |
|---|---|---|---|---|
| ⤷ Start Trial | Dec 7, 2029 | Almirall | SEYSARA | sarecycline hydrochloride |
| ⤷ Start Trial | Aug 10, 2028 | Almirall | SEYSARA | sarecycline hydrochloride |
| >US Patent Number | >US Expiration Date | >US Applicant | >US Tradename | >Generic Name |
